Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 15, 2005

View Archived Issues

NeuroMolecular receives award to support memantine development efforts

OvaRex MAb evaluated in new advanced ovarian cancer study

Subutex approved in Canada for opiate addiction treatment

FDA clears randomized portion of TNFerade pancreatic cancer study to proceed

Tev-Tropin launched in U.S.

Chemotherapeutic approach to control poxvirus infection with ErbB-1 inhibitor

FK-778, an immunosuppressant, prevents HCMV signaling and replication via inhibition of DHODH

Novel cannabinoid CB1 receptor agonists claimed by AstraZeneca

Five series of Src tyrosine kinase inhibitors reported by AstraZeneca

Testosterone MDTS improves sexual desire in women with HSDD

Update on the efficacy of rhThrombin in the management of surgery-associated bleeding

Phase III data on the effects of diquafosol ophthalmic solution in patients with dry eye

Efficacy and safety of combretastatin A-4 phosphate in the treatment of retinoblastoma

Controlled-release paroxetine reported safe and effective in panic disorder

Cerebral blood flow unaltered by BIBN-4096BS in healthy subjects

New phase II prostate cancer study for KOS-862

CEP-701 evaluated in patients with refractory malignancies

Solifenacin enhances quality of life in overactive bladder patients

Amantadine reduces weight gain from olanzapine treatment

First inhibitor of p90 ribosomal S6 kinase identified

FibroGen claims new hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors

New humanized anti-beta amyloid peptide monoclonal antibodies jointly reported by Neuralab and Wyeth

Novel NMDA/NR2B antagonists discovered at Merck

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...